M. Tellez

Neurofilament Levels in CSF and Serum in an Adult SMA Cohort Treated with Nusinersen.

W. Arnold, B. Elsheikh, K. Rajneesh, 2021, Journal of neuromuscular diseases.

Persistent neuromuscular junction transmission defects in adults with spinal muscular atrophy treated with nusinersen

W. Arnold, B. Elsheikh, Songzhu Zhao, 2021, BMJ Neurology Open.

Safety, Tolerability, and Effect of Nusinersen Treatment in Ambulatory Adults With 5q-SMA

W. Arnold, B. Elsheikh, Songzhu Zhao, 2021, Frontiers in Neurology.

Safety, Tolerability, and Effect of Nusinersen in Non-ambulatory Adults With Spinal Muscular Atrophy

W. Arnold, B. Elsheikh, Songzhu Zhao, 2021, Frontiers in Neurology.

Psychometric evaluation of modified spinal muscular atrophy functional rating scale (SMAFRS) in adult patients using Rasch analysis

W. Arnold, J. Montes, A. Bartlett, 2023, Muscle & nerve.

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

Adam L. Comer, Robert G. Miller, S. Demeret, 2023, The Lancet Neurology.

Neuromuscular disorders in a new toxic syndrome: Electrophysiological study—a preliminary report

A. C. Martínez, M. Conde, M. T. Ferrer, 1984, Muscle & nerve.

Differential impact on motor unit characteristics across severities of adult spinal muscular atrophy

K. Rajneesh, Kristina M Kelly, J. Reynolds, 2023, Annals of clinical and translational neurology.